Weight Loss Drug Belviq Pulled From Shelves After FDA Warns of Cancer Risk

Published Feb 14, 2020

Weight Loss Drug Belviq Pulled From Shelves After FDA Warns of Cancer Risk

A study designed to rule out heart-risk found a slightly higher incidence of cancer among those who took the drug for one year.

NOW
PLAYING
The Goal of R-CHOP
NOW
PLAYING
5 Biggest Risk Factors for Prostate Cancer; 'Today' Co-Host Al Roker's Diagnosis Shines New Light on This Disease
NOW
PLAYING
New Drug Selinexor (Xpovio) Has Many Risks, Limited Benefits Against Non-Hodgkin Lymphoma
NOW
PLAYING
Imbruvica Treats Relapsed Lymphoma in a Different Way
NOW
PLAYING
Treatment Options for Non-Hodgkin Lymphoma When the First Therapy Doesn't Work
NOW
PLAYING
Drug Cocktail Helps to Keep Non-Hodgkin Lymphoma Under Control

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.